Naegis Pharmaceuticals Inc.: developing novel, regulators of leukotriene pathways for serious inflammatory conditions
Naegis Pharmaceuticals Inc. Developing proprietary inhibitors of leukotriene synthesis (LTSIs) for treatment of Uveitis with potential for superior efficacy and better side effect profile – Proprietary molecules within the company’s…
